Compile Data Set for Download or QSAR
Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 7049
TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169633(US9079906, 117)
Affinity DataIC50: 98nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169631(US9079906, 89)
Affinity DataIC50: 107nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169650(US9079906, 239)
Affinity DataIC50: 113nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169641(US9079906, 186)
Affinity DataIC50: 119nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169640(US9079906, 178)
Affinity DataIC50: 126nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169642(US9079906, 197)
Affinity DataIC50: 149nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169646(US9079906, 221)
Affinity DataIC50: 155nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169644(US9079906, 207)
Affinity DataIC50: 174nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169639(US9079906, 174)
Affinity DataIC50: 183nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169643(US9079906, 199)
Affinity DataIC50: 206nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169645(US9079906, 215)
Affinity DataIC50: 219nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169648(US9079906, 230)
Affinity DataIC50: 234nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169638(US9079906, 168)
Affinity DataIC50: 257nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169625(US9079906, 14)
Affinity DataIC50: 279nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169637(US9079906, 163)
Affinity DataIC50: 364nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169636(US9079906, 161)
Affinity DataIC50: 365nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169647(US9079906, 222)
Affinity DataIC50: 416nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169651(US9079906, 240)
Affinity DataIC50: 484nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169627(US9079906, 50)
Affinity DataIC50: 631nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169635(US9079906, 144)
Affinity DataIC50: 827nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169629(US9079906, 76)
Affinity DataIC50: 951nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169626(US9079906, 26)
Affinity DataIC50: 1.10E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169632(US9079906, 101)
Affinity DataIC50: 1.40E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169649(US9079906, 236)
Affinity DataIC50: 1.40E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169634(US9079906, 127)
Affinity DataIC50: 2.50E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169630(US9079906, 84)
Affinity DataIC50: 9.80E+3nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent

TargetProteinase-activated receptor 1(Human)
Sanofi

US Patent
LigandPNGBDBM169628(US9079906, 56)
Affinity DataIC50: 2.40E+4nMpH: 7.5 T: 2°CAssay Description:The synthesized substances were examined in a PAR1 binding test. This tested whether the substances can inhibit the binding of a radioactively labele...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/7/2016
Entry Details
Go to US Patent